Rockefeller Capital Management
CGEM icon

Rockefeller Capital Management’s Cullinan Oncology CGEM Stock Holding History

Rockefeller Capital Management’s Portfolio CGEM Stock Details CGEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.8K Hold
649
– – ﹤0.01% 3944
2026
Q1 		$9.22K Buy
+649
New +$8.34K ﹤0.01% 4021
2022
Q3 		– Sell
-221
Closed -$2K – 3919
2022
Q2 		$2K Buy
+221
New +$2.51K ﹤0.01% 3756

Other funds holding CGEM

MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Rockefeller Capital Management's CGEM Position: Q2 2026 in Review

Rockefeller Capital Management held its Cullinan Oncology (CGEM) position steady in Q2 2026 at 649 shares worth $11.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3944.

Rockefeller Capital Management first reported a position in CGEM in Q2 2022 and has held it in 3 quarters since. 183 funds tracked by Wall St. Rank hold CGEM as of Q2 2026.

  • Rockefeller Capital Management held 649 shares of Cullinan Oncology worth $11.8K as of Q2 2026.
  • Rockefeller Capital Management left its Cullinan Oncology share count unchanged in Q2 2026.
  • Cullinan Oncology made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3944 holding.
  • Rockefeller Capital Management first reported a position in Cullinan Oncology in Q2 2022 and has held it in 3 quarters since.
  • 183 funds tracked by Wall St. Rank held Cullinan Oncology as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.